peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

GHRP

GHRP-2

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

GHRP-2 is categorized among growth hormone secretagogues, i.e., agents used to stimulate growth hormone secretion.

Sources for this introduction: [1]

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

GHRP-2 is categorized among growth hormone secretagogues, i.e., agents used to stimulate growth hormone secretion.

Sources[1]pubmedThe emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.growth hormone secretagogues (GHS; e.g., growth hormone-releasing peptide-2 (GHRP-2)[1]pubmedThe emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.growth hormone secretagogues (GHS; e.g., growth hormone-releasing peptide-2 (GHRP-2), growth hormone-releasing peptide-6 (GHRP-6), hexarelin, ipamorelin)
Source records
2
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “growth hormone secretagogues (GHS; e.g., growth hormone-releasing peptide-2 (GHRP-2)”

    The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. · Abstract

    pubmed:42395176:9df538e1edba:9df538e1edba
  2. supports · Source-backed record
    “growth hormone secretagogues (GHS; e.g., growth hormone-releasing peptide-2 (GHRP-2), growth hormone-releasing peptide-6 (GHRP-6), hexarelin, ipamorelin)”

    The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. · Abstract

    pubmed:42395176:9df538e1edba:9df538e1edba

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 6 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (2), assurance_score_below_0.72 (4), current_regulatory_source_required (1), extraction_ambiguity (6), high_risk_requires_regulatory_or_two_independent_sources (4), no_direct_support (6)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. ↗

    pubmed · published 2026-01-01 · retrieved 2026-08-17T23:10:15Z

Publication history and provenance

Version 4 · Automated assessment · 2026-08-26T20:13:52Z

8eb0f06d07cfa22d6b559ccf88bfcd9d8fe24d60d892450c8e3b6a61ea089ab6